Skip to content

www.windsorbux.com

Menu
  • Home
  • About Us
    • Windsor Bux
    • Our Values
    • Diversity Inclusion
    • Podcasts
    • Charity
  • Markets
    • VC & PE Portfolio Hiring
    • Pharmaceuticals &
       Biotech
  • Our Services
    • Retained Executive Search
    • Premium Contingent Recruitment
    • Project Management
    • Market intelligence
  • OUR RECRUITMENT EXPERTISE
    • Our Disciplines
    • Regulatory Affairs
    • Technical Operations
  • Contact us
  • Charity
Read more about the article Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics

Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics

  • Post author:admin
  • Post published:October 21, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Shehnaaz Suliman, M.D, CEO at ReCode TherapeuticsS2 Episode 6 of BioByteas by Windsor Bux welcomes Shehnaaz Suliman, M.D, CEO at ReCode TherapeuticsIn this episode of BioBytes, host Shak sits…

Continue ReadingShehnaaz Suliman, M.D, CEO at ReCode Therapeutics
Read more about the article Sandy Milligan, MD JD, C-Suite Executive & Board Member

Sandy Milligan, MD JD, C-Suite Executive & Board Member

  • Post author:admin
  • Post published:September 12, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Sandy Milligan, MD JD, C-Suite Executive & Board MemberS2 Episode 5 of BioByteas by Windsor Bux welcomes Sandy Milligan, MD JD, C-Suite Executive & Board Member. PresidentIn this episode of…

Continue ReadingSandy Milligan, MD JD, C-Suite Executive & Board Member
Read more about the article Alex Oshmyansky, MD, PhD, CEO / Co-Founder

Alex Oshmyansky, MD, PhD, CEO / Co-Founder

  • Post author:admin
  • Post published:August 18, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Alex Oshmyansky, MD, PhD, CEO / Co-Founder S2 Episode 4 of BioByteas by Windsor Bux welcomes Alex Oshmyansky, MD, PhD, CEO / Co-Founder Alex Oshmyansky, CEO and founder of…

Continue ReadingAlex Oshmyansky, MD, PhD, CEO / Co-Founder
Read more about the article Derek Adams, CEO & President

Derek Adams, CEO & President

  • Post author:admin
  • Post published:June 25, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Derek Adams, CEO & President S2 Episode 3 of BioByteas by Windsor Bux welcomes Derek Adams, CEO & President Derek Adams, CEO of Stellular Bio, shares his insights and…

Continue ReadingDerek Adams, CEO & President
Read more about the article Jason Cole – CEO & Chair of the Board, SalioGen

Jason Cole – CEO & Chair of the Board, SalioGen

  • Post author:admin
  • Post published:June 11, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Jason Cole - CEO & Chair of the Board, SalioGen S2 Episode 2 of BioByteas by Windsor Bux welcomes Jason Cole - CEO & Chair of the Board, SalioGen…

Continue ReadingJason Cole – CEO & Chair of the Board, SalioGen
Read more about the article David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund

David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund

  • Post author:admin
  • Post published:June 11, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast David Donabedian, PhD - Executive Partner, Interim NewCo CEO, Longwood Fund S2 Episode 1 of BioByteas by Windsor Bux welcomes David Donabedian, PhD - Executive Partner David Donabedian, a…

Continue ReadingDavid Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund
Read more about the article Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund

Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund

  • Post author:admin
  • Post published:April 11, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Stephanie Oestreich, PhD, MPA - Managing Director, Myeloma Investment Fund.Episode 8 of BioByteas by Windsor Bux welcomes Stephanie Oestreich, PhD, MPAStephanie Oestreich, Managing Director at Myeloma Investment Fund, shares…

Continue ReadingStephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund
Read more about the article Ronan O’Hagan, Chief Executive Officer

Ronan O’Hagan, Chief Executive Officer

  • Post author:admin
  • Post published:April 9, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Ronan O’Hagan, Chief Executive Officer Episode 3 of BioByteas by Windsor Bux welcomes Ronan O’Hagan, Chief Executive Officer. Ronan O'Hagan, CEO and President of Bectas Therapeutics, shares his insights…

Continue ReadingRonan O’Hagan, Chief Executive Officer
Read more about the article Alison Schecter, MD, CMO/CEO

Alison Schecter, MD, CMO/CEO

  • Post author:admin
  • Post published:April 9, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Alison Schecter, MD, CMO/CEOEpisode 7 of BioByteas by Windsor Bux welcomes Alison Schecter, MD, CMO/CEOAlison D. Schecter, an experienced biotech executive, shares insights and advice on leadership in the…

Continue ReadingAlison Schecter, MD, CMO/CEO
Read more about the article Joe Foster – Reebok, Founder

Joe Foster – Reebok, Founder

  • Post author:admin
  • Post published:April 8, 2024
  • Post category:Podcast
  • Post comments:0 Comments

Podcast Joe Foster – Reebok, Founder Episode 6 of BioByteas by Windsor Bux welcomes Joe Foster – Reebok, Founder Joe Foster, the visionary founder of Reebok, shares his entrepreneurial journey…

Continue ReadingJoe Foster – Reebok, Founder
  • 1
  • 2
  • Go to the next page
  • Shehnaaz Suliman, M.D, CEO at ReCode TherapeuticsOctober 21, 2024
  • Sandy Milligan, MD JD, C-Suite Executive & Board MemberSeptember 12, 2024
  • Alex Oshmyansky, MD, PhD, CEO / Co-FounderAugust 18, 2024
  • Derek Adams, CEO & PresidentJune 25, 2024
  • Jason Cole – CEO & Chair of the Board, SalioGenJune 11, 2024
  • David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood FundJune 11, 2024
  • Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment FundApril 11, 2024
  • Ronan O’Hagan, Chief Executive OfficerApril 9, 2024
  • Alison Schecter, MD, CMO/CEOApril 9, 2024
  • Joe Foster – Reebok, FounderApril 8, 2024

Speak to a Consultant Today

Contact Us

Windsor Bux provides first class recruitment services to the Life Sciences sector. We operate internationally across Mid to Senior level appointments on a Premium Permanent Contingent & Executive Search retained base model.

READ MORE >

Useful Links

  • About Us
  • Premium Contingent
    Recruitment
  • Executive Search
  • Market Intelligence
  • Our Disciplines
  • Regulatory Affairs
  • Charity
  • Contact Us

London - HQ

  • + 44 33 0052 1070
  • office@windsorbux.com
  • Windsor Bux
    Westlink House
    981 Great West Road
    TW8 9DN

Windsor

  • + 1 617 982 1810
  • office@windsorbux.com
  • Windsor Bux
    Castle Hill House
    12 Castle Hill
    Windsor
    SL4 1PD

New York

  • + 1 908 845 8010
  • office@windsorbux.com
  • Windsor Bux
    445 Park Avenue Manhattan
    NY 10022 USA

Dubai

  • +971 (0) 4554 7586
  • office@windsorbux.com
  • Windsor Bux
    Grosvenor Business Tower, Office 1409
    Dubai, UAE
© Windsor Bux Limited All rights reserved. | Privacy Policy